By continuing browsing, you agree to the storing of cookies on your device to enhance your site experience and for analytical purposes. To learn more about how we use the cookies, please see our Cookie Policy.
Overview
MediWound is a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, biotherapeutic solutions for tissue repair and regeneration.
Our strategy leverages our enzymatic technology platform, focused on next-generation bio active therapies for burn, wound care and tissue repair.
NexoBrid, our commercial orphan biological product for eschar removal of severe thermal burns, is a bromelain-based biological product containing a sterile mixture of proteolytic enzymes that selectively removes burn eschar within four hours and does not harm surrounding viable tissue.
Nexobrid is currently marketed in the European Union as well as in other International markets and is at registration stage in the U.S. NexoBrid is supported by the U.S. Biomedical Advanced Research and Development Authority (BARDA).
EscharEx, our next-generation bioactive topical therapy for debridement of chronic and hard-to-heal wounds, is a product candidate in advanced stages of development. In two Phase 2 studies, EscharEx was well-tolerated and has demonstrated safety and efficacy in the debridement of various chronic and other hard-to-heal wounds, with only a few daily applications.
MW005, our topical biological drug for the treatment of non-melanoma skin cancers, is a clinical-stage product candidate under development.
Our Culture
We believe that a great part of our success is fueled by our people and our values. Our culture is the compass for our day to day operations and our people navigate the way, creating the greatest value to our stakeholders.
“At MediWound, great teams take great ideas and make them happen. We are here to make a difference in standard of care. We think about the many tomorrows our patients can enjoy, always seeking to create a better life for them”
"I take enormous pleasure in knowing that my goal of making NexoBrid available to all patients has come to fruition, changing burn care for thousands of patients worldwide. For me, as a physician, to be able to leave this footprint in medicine is the greatest possible reward"
The Full Solution
MediWound has extensive history and experience developing, manufacturing, and commercializing regenerative medicinal products
In-house Expertise
State of the Art Facility
Wide global network
Our Team
Chief Executive Officer
Chief Medical Technology Officer
Chief R&D Officer
Chief Financial Officer
Executive Vice President & General Counsel
VP Plant Manager
VP Clinical Affairs
VP Finance
VP R&D
VP Regulatory Affairs
VP Quality
Executive Chairman
Board Member
Board Member
Board Member
Board Member
Board Member
Board Member
Board Member
Testimonials
Join Us
A collaborative, focused, and creative environment
We are focused on seeking cures and advancing care. Join us and together we can influence patient outcomes and quality of care.
“At MediWound, great teams take great ideas and make them happen. We are here to make a difference in standard of care. We think about the many tomorrows our patients can enjoy, always seeking to create a better life for them”
Chief Executive Officer
"I take enormous pleasure in knowing that my goal of making NexoBrid available to all patients has come to fruition, changing burn care for thousands of patients worldwide. For me, as a physician, to be able to leave this footprint in medicine is the greatest possible reward"
Chief Medical Technology Officer
"At MediWound, science, technological innovation and deep industry knowledge expands our portfolio with new bio-therapeutic solutions for unmet medical needs"
Chief R&D Officer
"In MediWound, we harness innovation, commitment, dedication and determination to change treatment paradigms to help patients’ in their times of pain. To see their relief is the most rewarding thing for us to cherish. It keeps driving us every single day"
Chief Financial Officer
"Creativity is thinking up new things. Innovation is doing new thing. At MediWound, we are privileged to have both, allowing us to improve our patients' lives and the standard of care."
Executive Vice President & General Counsel
"Establishing a state of the art cGMP sterile facility that takes the pineapple stem and makes it a pharmaceutical drug is a life accomplishment"
VP Plant Manager
“Clinical trials are important for discovering new treatments for diseases, as well as new ways to detect, diagnose, and reduce the chance of developing diseases. I’m proud to be part of all discoveries achieved in the last 20 years in the clinical development of our products and having new therapies available to patients”
VP Clinical Affairs
"I have the privilege to work to grow and develop with the company throughout the years, from a small startup to an established publicly traded company. The level of professional, commitment and high excellence of the company together with the way we improve patients’ lives is what drives me"
VP Finance
"Deep and robust foundations, are the key to every solid building. I am proud to lead the pre-clinical as well as the Chemistry, Manufacturing and Controls (CMC) development at MediWound. By a team work, my group is establishing the foundations for turning vision to reality"
VP R&D
"Regulatory affairs are the final stamp for our products and we are keen to maintain it at the highest standards. I’m proud of the experience, knowhow and knowledge we have acquired in the last 20 years, working with all major health authorities and bringing NexoBrid to the burn patients"
VP Regulatory Affairs
"Quality is a crucial component of becoming an excellent organization. It is what enable us to provide the value with assuring the quality of our products and the safeness of our patients"
VP Quality
Executive Chairman
Board Member
Board Member
Board Member
Board Member
Board Member
Board Member
Board Member